2016;77(4):e457e466
These are standard precautions and regulatory review will determine the full contraindication and warning profile ahead of any potential market authorisation
Possible risks with Zepbound and Ozempic include: Complications of the eye disease diabetic retinopathy in people with type 2 diabetes Gallbladder disease Low blood sugar (hypoglycemia) Lung aspiration ( inhaling food or fluids into the lungs) during general anesthesia or deep sedation for a medical procedure Severe allergic reactions like anaphylaxis Kidney injury Gallstones or inflammation of the gallbladder Inflammation of the pancreas (pancreatitis) Who should not take Zepbound or Ozempic
Five additional peptides LL-37, GHK-Cu, Dihexa acetate, Melanotan II, and PEG-MGF are scheduled for a second PCAC meeting to be held before the end of February 2027
125 As with other clinically applicable scores and indices, it is mandatory to review such calculations periodically, as experience with other prognostic instruments has shown that their reliability may need to be scrutinized 126 from time to time
Peptides Where Weight Matters Less : GHSs ( Ipamorelin , CJC-1295 ), BPC-157 , TB-500
